Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 21 Projects
Project # Contact PI Funding Organization Fiscal Year
Impact of white adipose tissue on tau pathology in transgenic mice
AARG-22-928219 Baglietto-Vargas, David Alzheimer's Association 2022
Unveiling the impact of biological sex along sporadic and genetic FTLD
AACSF-21-850193 Ignacio Illán-Gala Alzheimer's Association 2021
Microstructural changes in primary progressive aphasia
GBHI ALZ UK-21-720973 Illán-Gala, Ignacio Alzheimer's Association 2021
Tau and adult neurogenesis. Therapeutic potential for frontotemporal degeneration
AFTD-Llorens-Martí-2017 Llorens-Martín, María The Association for Frontotemporal Degeneration 2017
A2A receptors and Tauopathy
EUJPND-FranceANR-BLUM-621 BLUM, DAVID Agence Nationale de la Recherche (ANR) 2016
Spreading of Tau assemblies
EUJPND-FranceANR-BUEE-625 BUEE, Luc Agence Nationale de la Recherche (ANR) 2016
Predict to prevent frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)
EUJPND-FranceANR-Le BER-644 Le BER, Isabelle Agence Nationale de la Recherche (ANR) 2016
PREDICT. Predict-PGRN- Prospective multimodal characterization of frontotemporal dementia due to mutations of the PGRN gene at a symptomatic and presymptomatic stage / PREDICT.
EUJPND-FoundPlanAlz-BRICE-666 BRICE, Alexis Fondation Plan Alzheimer 2016
STUDY OF THE EXOSOMAL MICRORNA EXPRESSION PROFILE IN BIOFLUIDS FOR THE IDENTIFICATION OF DIAGNOSTIC USE BIOMARKERS IN FRONTOTEMPORAL DEMENTIA
EUJPND-SpainISC-CLARIMON ECHAVARRIA-1324 CLARIMON ECHAVARRIA, JORDI INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
PROGRESSION OF SMALL CEREBRAL VASCULAR DISEASE: RISK FACTORS, IMPLICATED MECHANISMS AND CLINICAL CONSEQUENCES.
EUJPND-SpainISC-DELGADO MARTINEZ-1326 DELGADO MARTINEZ, MARIA PILAR INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016